Concerning the combined criteria, CDKN2A/B deletion is indeed more frequent in IDHm astrocytomas with morphological WHO grade 4 criteria compared to the morphological lower-grade astrocytomas [4, 9]. The gene discussed is CDKN2A; the disease is astrocytoma (excluding glioblastoma).